Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

TranS1 Inc. Schedules Fourth Quarter 2012 Results Conference Call for Monday, March 4, 2013

TranS1 Inc. Schedules Fourth Quarter 2012 Results Conference Call for Monday,
March 4, 2013

WILMINGTON, N.C., Feb. 20, 2013 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON)
announced today that it plans to release fourth quarter 2012 financial and
operating results after market close on Monday, March 4, 2013. Ken Reali,
President and Chief Executive Officer of TranS1, and Joe Slattery, Chief
Financial Officer, will host a conference call starting at 4:30 pm ET on the
same day. To listen to the conference call on your telephone, please dial
(877) 881-2183 for domestic callers and (970) 315-0453 for international
callers approximately ten minutes prior to the start time. The call will be
concurrently webcast. To access the live audio broadcast or archived
recording, use the following link at

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and
marketing products to treat degenerative conditions of the spine affecting the
lumbar region. TranS1 currently markets the AxiaLIF® family of products for
single and two level lumbar fusion, the VEO^TM direct lateral access and
interbody fusion system and the Vectre^TM posterior fixation system for lumbar
fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is
headquartered in Wilmington, North Carolina. For more information, visit

CONTACT: TranS1 Inc.
         Joe Slattery, Chief Financial Officer
         Westwicke Partners
         Mark Klausner
Sponsored Links
Sponsored Links